<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-IL121FKA</identifier><date>2024</date><creator>Baumgartner, Ana</creator><relation>documents/doc/I/URN_NBN_SI_doc-IL121FKA_001.pdf</relation><relation>documents/doc/I/URN_NBN_SI_doc-IL121FKA_001.txt</relation><format format_type="issue">1</format><format format_type="volume">75</format><format format_type="type">article</format><format format_type="extent">str. 34-42</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">192524035</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-IL121FKA</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">bolnikom prijazne farmacevtske oblike</subject><subject language_type_id="eng">coprocessed excipients</subject><subject language_type_id="eng">direct compression</subject><subject language_type_id="slv">direktno stiskanje</subject><subject language_type_id="slv">Etika</subject><subject language_type_id="slv">Farmacevtske oblike</subject><subject language_type_id="slv">koprocesirane pomožne snovi</subject><subject language_type_id="eng">orodispersible tablets</subject><subject language_type_id="slv">orodisperzibilne tablete</subject><subject language_type_id="eng">patient-friendly dosage forms</subject><subject language_type_id="slv">Tablete</subject><title>Uporaba koprocesiranih pomonih snovi pri izdelavi orodisperznibilnih tablet</title><title>Use of coprocessed excipients in orodispersible tablets</title></Record>